'By hook or by crook': BIO CEO urges biotechs to be flexible on funding to survive tough times

After nearly a year, King's reign as CEO is likely coming to a close, the interim BIO leader explained at the Fierce Biotech Summit early last week. The organization is actively conducting a search for a permanent successor, she told Fierce Biotech.